CYTK- Cytokinetics, Incorporated
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.54M | - | |
| VP | 141.5K | $11.15M | - | |
| Other | 87.3K | $6.88M | - | |
| VP | 73.6K | $5.79M | -15,000 | |
| CFO | 70.1K | $5.52M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Kaye Edward M. Md46 | Director | Sell | 2,933 | $76.09 | $223,171.97 | -22.2% | - | - | |
| Jun 1, 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 15,000 | $74.08 | $1,111,200.00 | -20.4% | - | - | |
| Jun 1, 2026 | Parshall B Lynne74 | Director | Sell | 5,000 | $74.08 | $370,400.00 | -24.1% | - | - | |
| May 14, 2026 | Blum Robert I51 | President &CEO | Sell | 7,500 | $77.92 | $584,400.00 | -1.8% | - | - | |
| Apr 15, 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 7,449 | $66.02 | $491,782.98 | -11.3% | - | - | |
| Apr 15, 2026 | Blum Robert I51 | President &CEO | Sell | 7,500 | $65.38 | $490,350.00 | -1.8% | - | - | |
| Mar 17, 2026 | Blum Robert I51 | President &CEO | Sell | 36,601 | $62.15 | $2,274,752.15 | -4.0% | +12.9% | - | |
| Jan 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 15,000 | $60.28 | $904,200.00 | -22.9% | +6.0% | - | |
| Jan 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 1,798 | $62.62 | $112,584.77 | -1.8% | +8.1% | - | |
| Dec 29, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 1,809 | $62.44 | $112,953.96 | -3.4% | +2.0% | - |
Page 1Next →